Skip to main content

FDA approves new Eli Lilly drug to 'resolve' migraine pain in two hours

The U.S. Food and Drug Administration approved a drug to help prevent migraines on Thursday. The drug, Reyvow, was developed by Eli Lilly and Co. and has proven effective in alleviating the painful symptoms of migraines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.